ANPC

AnPac Bio-Medical Science Co., Ltd. [ANPC] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ANPC Stock Summary

In the News

ANPC Financial details

Company Rating
-
Market Cap
26.97M
Income
-101.32M
Revenue
12.04M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
89
Optionable
No
Shortable
Yes
Earnings
16 May 2023
P/E
-0.58
Forward P/E
-
PEG
0.11
P/S
16.06
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-87.27
EPS next Y
-
EPS next Q
-
EPS this Y
-69.31%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
70.5%
Revenue last 5Y
3.28%
Revenue Q/Q
-93.17%
EPS Q/Q
21.15%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
6243%
ROC
-
Gross Margin
69%
Oper. Margin
-870%
Profit Margin
-841%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.6-11.99
52W High
-
52W Low
-
RSI
-
Rel Volume
1.62
Avg Volume
22.07K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.55985
-
-
Volatility
0.03%, 0.03%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
META
LLY
NVD.DE
MSF.DE
EMBASSY.NS
Same Sector
MRAI
CIZ.L
1681.HK
OGI.TO
099190.KQ
Check Those
BLUE
SAP.DE
STPU.L
DBJA
2423.TW
Similar Market Cap
6080.HK
CIBH
UTSI
SPYT.DE
LBUL.L

Company Profile

Healthcare Biotechnology
  • Volume Average 22.07K
  • Market Capitalization 26.97M
  • Employee 89
  • CEO Dr. Chris Chang Yu
  • Headquarters Lishui,CN
  • IPO Date 2020-01-30
  • Website https://www.anpacbio.com

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.